Overview

Psilocybin for Treatment-Resistant Depression

Status:
RECRUITING

Trial end date:
2026-03-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the efficacy of psilocybin on the symptom of anhedonia in individuals with treatment-resistant major depressive disorder.

Phase:

PHASE2

Details

Lead Sponsor:

University of Colorado, Denver

Treatments:

Psilocybin